U.S. market Closed. Opens in 1 day 8 hours 39 minutes

ADIL | Adial Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue564.0060.50K55.11K564.00565.00563.00565.00565.00565.00
Gross Profit-564.00-60.50K-55.11K-564.00-565.00-563.00-565.00-565.00-565.00
Operating Expenses6.89M13.32M17.74M10.93M8.24M6.99M995.29K410.81K819.26K
Selling, General & Admin5.62M9.14M9.34M5.07M4.28M6.62M813.18K264.66K497.15K
Research & Development1.27M4.18M8.40M5.85M3.97M368.46K182.11K146.14K322.11K
Other Operating ExpensesN/AN/A46.49K2.50KN/AN/AN/AN/AN/A
Operating Income-6.89M-13.32M-19.29M-10.93M-8.24M-6.99M-995.29K-410.81K-819.26K
Other Expenses / Income-113.94K585.21K-1.82M34.99K-346.53K-4.64M-144.17K-9.39K1.26K
Before Tax Income-7.00M-12.73M-19.52M-10.89M-8.59M-11.63M-1.14M-420.20K-817.99K
Income Tax ExpensesN/A-502.00-94.08K-32.49K-76.06K-3.48M367.009.64K1.26K
Net Income-7.00M-12.73M-19.42M-10.86M-8.59M-11.63M-1.14M-420.20K-817.99K
Interest ExpensesN/AN/AN/AN/AN/A1.17M144.54K9.64KN/A
Basic Shares Outstanding1.42M1.06M743.55K498.52K394.10K190.37K218.99K191.13K191.28K
Diluted Shares Outstanding1.42M1.06M743.55K498.52K394.10K190.37K218.99K191.13K191.28K
EBITDA-7.00M-13.32M-19.46M-10.93M-8.15M-6.98M-994.35K-410.00K-817.43K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-7.00M-12.73M-19.52M-10.89M-8.67M-13.94M-994.55K-400.91K-816.73K
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙